Joel Isaacson & Co., LLC - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 158 filers reported holding ZIOPHARM ONCOLOGY INC in Q2 2016. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.

Quarter-by-quarter ownership
Joel Isaacson & Co., LLC ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q4 2016$18,000
-5.3%
3,3500.0%0.00%0.0%
Q3 2016$19,000
+5.6%
3,3500.0%0.00%0.0%
Q2 2016$18,000
-28.0%
3,3500.0%0.00%
-33.3%
Q1 2016$25,000
-10.7%
3,3500.0%0.01%
-14.3%
Q4 2015$28,000
-6.7%
3,3500.0%0.01%
-12.5%
Q3 2015$30,000
-25.0%
3,3500.0%0.01%
-20.0%
Q2 2015$40,0003,3500.01%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q2 2016
NameSharesValueWeighting ↓
DISCOVERY CAPITAL MANAGEMENT, LLC / CT 15,461,829$2,037,8690.36%
MSD Partners, L.P. 15,151,516$1,996,9700.16%
MSD Partners, L.P. 7,575,758$998,4850.08%
MAGNOLIA CAPITAL ADVISORS LLC 865,938$65,5520.03%
Allred Capital Management, LLC 253,000$33,3450.02%
CHIRON CAPITAL MANAGEMENT, LLC 77,023$10,1520.01%
Boxer Capital, LLC 1,100,000$144,9800.01%
GSA CAPITAL PARTNERS LLP 569,566$750.01%
Sugarloaf Wealth Management, LLC 75,500$9,9510.00%
Owen LaRue, LLC 11,825$1,5590.00%
View complete list of ZIOPHARM ONCOLOGY INC shareholders